Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Dympna Harmey, Patrick R. Griffin, Paul J. Kenny
Nicotine & Tobacco Research (2012) Vol. 14, Iss. 11, pp. 1300-1318
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Daniel Himmelstein, Antoine Lizée, Christine Hessler, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 446
Neurobiological Mechanisms of Nicotine Reward and Aversion
Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 271-310
Open Access | Times Cited: 73
Nicotine Replacement Therapy : An Overview
Umesh Wadgave, L Nagesh
International Journal of Health Sciences (2016) Vol. 10, Iss. 3, pp. 407-416
Open Access | Times Cited: 128
Smoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Amedeo Minichino, Francesco Saverio Bersani, Wanda Katharina Calò, et al.
International Journal of Environmental Research and Public Health (2013) Vol. 10, Iss. 10, pp. 4790-4811
Open Access | Times Cited: 91
The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics
Glenda Lassi, Amy E. Taylor, Nicholas J. Timpson, et al.
Trends in Neurosciences (2016) Vol. 39, Iss. 12, pp. 851-861
Open Access | Times Cited: 74
Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation
Xia Li, Svetlana Semenova, Manoranjan S. D’Souza, et al.
Neuropharmacology (2013) Vol. 76, pp. 554-565
Open Access | Times Cited: 72
Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum
Shannon L. Wolfman, Daniel Gill, Fili Bogdanic, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 63
The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys
Zuzana Justinová, Leigh V. Panlilio, Maria E. Secci, et al.
Biological Psychiatry (2015) Vol. 78, Iss. 7, pp. 452-462
Open Access | Times Cited: 57
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Peter A. Crooks, Michael T. Bardo, Linda P. Dwoskin
Advances in pharmacology (2014), pp. 513-551
Open Access | Times Cited: 50
A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity
Jonathan W. Lockner, Jenny M. Lively, Karen Collins, et al.
Journal of Medicinal Chemistry (2014) Vol. 58, Iss. 2, pp. 1005-1011
Closed Access | Times Cited: 37
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
Rebecca L. Ashare, Heath D. Schmidt
Expert Opinion on Drug Discovery (2014) Vol. 9, Iss. 6, pp. 579-594
Open Access | Times Cited: 37
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Daniel Himmelstein, Antoine Lizée, Christine Hessler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2016)
Open Access | Times Cited: 35
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Hans Rollema, Raymond S Hurst
Psychopharmacology (2018) Vol. 235, Iss. 9, pp. 2479-2505
Closed Access | Times Cited: 32
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation
Kenneth A. Perkins, Caryn Lerman
Psychopharmacology (2013) Vol. 231, Iss. 1, pp. 1-11
Open Access | Times Cited: 32
Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse
Justin J. Taylor, Megan Laudenbach, Ashli M. Tucker, et al.
Journal of Immunological Methods (2014) Vol. 405, pp. 74-86
Open Access | Times Cited: 30
Formatting biological big data for modern machine learning in drug discovery
Miquel Duran‐Frigola, Adrià Fernández‐Torras, Martino Bertoni, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2018) Vol. 9, Iss. 6
Closed Access | Times Cited: 26
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Heath D. Schmidt, Laura E. Rupprecht, Nii Addy
Complex Psychiatry (2018) Vol. 4, Iss. 4, pp. 169-189
Open Access | Times Cited: 25
mGluR2/3 mediates short‐term control of nicotine‐seeking by acute systemic N‐acetylcysteine
Federico Moro, Alessandro Orrù, C Marzo, et al.
Addiction Biology (2016) Vol. 23, Iss. 1, pp. 28-40
Closed Access | Times Cited: 23
Impact of a novel interprofessional dental and pharmacy student tobacco cessation education programme on dental patient outcomes
Shannon Myers Virtue, Melissa E. Rotz, Matthew Boyd, et al.
Journal of Interprofessional Care (2017) Vol. 32, Iss. 1, pp. 52-62
Closed Access | Times Cited: 23
Pathways and Networks-Based Analysis of Candidate Genes Associated with Nicotine Addiction
Meng Liu, Rui Fan, Xinhua Liu, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0127438-e0127438
Open Access | Times Cited: 23
New treatments for COPD
Anta Ngkelo, Ian M. Adcock
Current Opinion in Pharmacology (2013) Vol. 13, Iss. 3, pp. 362-369
Closed Access | Times Cited: 20
Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence
Kenneth A. Perkins, Joshua L. Karelitz, Valerie C. Michael, et al.
Nicotine & Tobacco Research (2015), pp. ntv085-ntv085
Open Access | Times Cited: 18
r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement
Joshua S. Beckmann, Andrew C. Meyer, Marharyta Pivavarchyk, et al.
Neurochemical Research (2015) Vol. 40, Iss. 10, pp. 2121-2130
Open Access | Times Cited: 17
Δ8‐Tetrahydrocannabivarin has potent anti‐nicotine effects in several rodent models of nicotine dependence
Zheng‐Xiong Xi, Pretal P. Muldoon, Xiao‐Fei Wang, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 24, pp. 4773-4784
Open Access | Times Cited: 15
A biomedical open knowledge network harnesses the power of AI to understand deep human biology
Sergio E. Baranzini, Katy Börner, John P. Morris, et al.
AI Magazine (2022) Vol. 43, Iss. 1, pp. 46-58
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top